| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | 4 | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.29 |
—
—
—
|
| 2025 | 0.28 |
—
—
—
—
|
| 2024 | 0.28 |
—
—
—
—
|
| 2023 | 0.44 |
—
—
—
—
|
| 2022 | 0.92 |
—
—
—
—
|
| 2021 | 0.92 |
—
—
—
—
|
| 2020 | 0.92 |
—
—
—
—
|
| 2019 | 0.92 |
—
—
—
—
|
| 2018 | 0.92 |
—
—
—
—
|
| 2017 | 0.88 |
—
—
—
—
|
| 2016 | 0.76 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 332.00 | 198.00 | 203.00 | 209.00 |
| Receivables | 1,195.00 | 878.00 | 987.00 | 1,025.00 |
| Inventory | 1,531.00 | 1,400.00 | 1,281.00 | 1,491.00 |
| Other | — | — | — | — |
| 3,354.00 | 2,775.00 | 2,708.00 | 3,208.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,003.00 | 891.00 | 931.00 | 1,054.00 |
| ST’ Debt | 329.00 | 87.00 | 130.00 | 470.00 |
| Other | — | — | — | — |
| 2,897.00 | 2,437.00 | 2,525.00 | 2,888.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,549.00 | 1,994.00 | — | — |
—
|
| ’25 | 1,566.00 | 1,935.00 | 1,806.00 | 1,897.00 |
7,204.00
|
| ’24 | 1,653.00 | 2,033.00 | 1,947.00 | 1,949.00 |
7,582.00
|
| ’23 | 1,805.00 | 2,204.00 | 2,048.00 | 2,076.00 |
8,133.00
|
| ’22 | 2,388.00 | 2,534.00 | 2,252.00 | 2,285.00 |
9,459.00
|
| ’21 | 2,288.00 | 2,709.00 | 2,787.00 | 2,805.00 |
10,589.00
|
| ’20 | 1,886.00 | 2,111.00 | 2,699.00 | 2,689.00 |
9,385.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (233.00) | 29.00 | — | — |
—
|
| ’25 | (213.00) | (58.00) | 374.00 | 161.00 |
264.00
|
| ’24 | 32.00 | 32.00 | 282.00 | 150.00 |
496.00
|
| ’23 | (77.00) | 354.00 | 402.00 | 251.00 |
930.00
|
| ’22 | (272.00) | (178.00) | (117.00) | 295.00 |
(272.00)
|
| ’21 | (25.00) | 101.00 | 414.00 | 394.00 |
884.00
|
| ’20 | 23.00 | 109.00 | 688.00 | 612.00 |
1,432.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (270.00) | (18.00) | — | — |
—
|
| ’25 | (272.00) | (117.00) | 315.00 | 91.00 |
17.00
|
| ’24 | (27.00) | (21.00) | 231.00 | 54.00 |
237.00
|
| ’23 | (160.00) | 295.00 | 335.00 | 176.00 |
646.00
|
| ’22 | (342.00) | (248.00) | (198.00) | 204.00 |
(584.00)
|
| ’21 | (79.00) | 41.00 | 347.00 | 286.00 |
595.00
|
| ’20 | (35.00) | 73.00 | 624.00 | 511.00 |
1,173.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.08) | 0.25 | — | — |
—
|
| ’25 | (0.09) | 0.11 | 0.05 | (0.75) |
(0.68)
|
| ’24 | (0.02) | 0.11 | (0.48) | (0.13) |
(0.52)
|
| ’23 | (0.25) | 0.04 | (0.53) | (0.21) |
(0.94)
|
| ’22 | 0.55 | 0.49 | 0.07 | (0.60) |
0.47
|
| ’21 | 0.21 | 0.46 | 0.44 | 0.22 |
1.34
|
| ’20 | (3.02) | 0.18 | 0.71 | 0.30 |
(1.82)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.25 | 6.50 | 5.39 | 3.07 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 26.45 | 16.76 | 11.78 | 10.85 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28,000 | 24,600 | 23,700 | 21,900 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.34 | 0.33 | 0.32 | 0.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,459.00 | 8,133.00 | 7,582.00 | 7,204.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.96% | 28.93% | 33.61% | 33.76% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 157.00 | (543.00) | (260.00) | (301.00) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.66% | (6.68%) | (3.43%) | (4.18%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 197.00 | (388.00) | (216.00) | (285.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 770.00 | 676.00 | 676.00 | 657.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.75 | 19.64 | 18.25 | 17.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 0.47 | (0.94) | (0.52) | (0.68) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.65) | 2.25 | 1.19 | 0.63 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.75) | (0.69) | (0.62) | (0.59) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.40) | 1.56 | 0.57 | 0.04 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.47 | 7.52 | 6.62 | 5.72 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 415.70 | 414.10 | 415.50 | 418.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 26.39 | 0.00 | 0.00 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.59 | 0.45 | 0.55 | 0.22 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.59 | 1.16 | 1.50 | 0.65 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.13 | 1.01 | 1.13 | 0.84 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.30) | 12.68 | 36.01 | 354.45 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (272.00) | 930.00 | 496.00 | 264.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (312.00) | (284.00) | (259.00) | (247.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (584.00) | 646.00 | 237.00 | 17.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 974.00 | 457.00 | 338.00 | 183.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,377.00 | 4,904.00 | 4,595.00 | 4,673.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,090.00 | 4,572.00 | 4,397.00 | 4,470.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,519.00 | 3,112.00 | 2,751.00 | 2,391.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.43% | (3.05%) | (1.86%) | (2.62%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.27% | (0.69%) | 0.59% | 0.36% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.13% | (11.70%) | (7.37%) | (11.09%) | — | — | — |
ROE
|
Newell Brands (NWL) exemplifies the pitfalls of aggressive acquisitions in consumer goods, with the 2016 $13.2B Jarden merger triggering revenue stagnation, a massive 2018 goodwill impairment, and shares plunging 80-88% from peaks to multi-year lows near $5-6. Revenue eroded from a 2017 high of $11.17B to $7.58B in 2024 (-32%), stabilizing at $7.2-7.3B through 2027 per forecasts, buoyed by workforce cuts (56% reduction) that lifted revenue per employee to $320K despite per-share sales dropping 21%. Stock metrics reflect skepticism: PS ratios compressed to 0.55x from 2.06x, mirroring post-pandemic destocking and inflation woes.
Profitability scars linger—EBT swung from +8.2% margins in 2017 to -78.7% in 2018, with recent losses narrowing to -3.4% in 2024 amid gross margin rebounds to 33.6% and 61% debt reduction to $4.6B. Cash flows turned positive (FCF/share $0.57), ROIC at 0.6%, but ROE remains negative at -7.4%, equity halved to $2.75B. Insider activity is neutral, with minimal sells signaling caution.
Trading at distressed multiples (PS 0.55x, PB 1.5x), NWL offers a turnaround bet under CEO Peterson’s cost cuts and portfolio pruning, with analysts eyeing EPS positivity ($0.45-$0.63 by 2027) and mean 6% upside (high +70%). Risks from tariffs, private labels, and recession loom, demanding flawless execution for 10-15% annualized returns—read the full analysis for quantitative models dissecting these probabilities.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.